XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenue $ 11,566 $ 7,349 $ 31,946 $ 21,170
Cost of goods sold 1,906 1,004 5,203 2,887
Gross profit 9,660 6,345 26,743 18,283
Operating expenses        
Research and development [1] 5,176 4,219 12,395 14,729
Sales and marketing 6,839 6,138 20,736 18,829
General and administrative [1] 6,659 4,727 17,287 13,310
Loss from operations (9,014) (8,739) (23,675) (28,585)
Other income (expense)        
Interest income 170 158 378 347
Interest expense (1,460) (1,142) (4,092) (2,022)
Change in fair value of SEPA, warrant and revenue base redemption liabilities (2,932) 4,974 (4,097) (1,521)
Change in fair value of contingent earnout liability 2,524 2,360 2,404 12,061
Other expense, net (94) (13) (385) (210)
Loss before income taxes (10,806) (2,402) (29,467) (19,930)
Income tax benefit (expense) (5) 3 (7) (7)
Net loss (10,811) (2,399) (29,474) (19,937)
Series A Preferred Stock conversion inducement (18,516) 0 (18,516) 0
Deemed dividend related to Series A Preferred Stock conversion (11,947) 0 (11,947) 0
Undeclared dividends on Series A Preferred Stock 0 (803) 0 (2,405)
Net loss attributable to common stockholders $ (41,274) $ (3,202) $ (59,937) $ (22,342)
Net loss per common share, basic (in dollars per share) $ (0.96) $ (0.12) $ (1.72) $ (0.91)
Net loss per common share, diluted (in dollars per share) $ (0.96) $ (0.12) $ (1.72) $ (0.91)
Weighted average common shares outstanding, basic (in shares) 43,057,632 26,501,597 34,858,162 24,588,500
Weighted average common shares outstanding, diluted (in shares) 43,057,632 26,501,597 34,858,162 24,588,500
[1]
(1) Amounts presented in prior 2025 interim periods have been revised in the year to date ended September 30, 2025 to align expense classification for the year to date period.